#Japan #Tokyo #Ultrasound #Philips #Transcend Plus

Introduction to Transcend Plus Series

On August 1, 2025, Philips Japan unveiled its latest innovation in cardiovascular ultrasound diagnostics with the launch of the EPIQ/Affiniti CVx Transcend Plus series. This new line comes as a response to the escalating global death rates from cardiovascular diseases (CVD), which have surged by 60% in the last 30 years, becoming a leading cause of mortality as of 2021. The healthcare sector faces increasing challenges amidst a predicted shortage of approximately 100,000 medical professionals by 2028. Amidst this backdrop, the integration of AI technology into medical devices is becoming increasingly vital to enhance diagnostic efficiency and accuracy.

Key Features of Transcend Plus Series

1. Improved Image Quality for Reliable Diagnostics

The Transcend Plus series boasts significant upgrades in imaging technology, including enhancements to nSIGHT Plus, XRes, and Image Boost, which are designed to elevate the quality of echocardiograms. The series includes the newly designed X11-4t endoscopic transducer, known for its thin profile that supports 2D and 3D imaging. This advancement is particularly beneficial for the clinical diagnosis of pediatric patients with high heart rates, enabling medical professionals to gather more reliable data while reducing examination time.

2. Enhanced Efficiency through AI Technology

Equipped with cutting-edge AI modules, the Transcend Plus series features the R-Trigger technology, which integrates heart rate detection with ECG data. This technology supports automatic measurement functions such as Auto Measure, AutoStrain LV for strain analysis, and the calculation of ejection fraction via 2D Auto EF, improving both routine tests and efficiency. Furthermore, the Auto SWM (Segmental Wall Motion) function has been optimized with an expanded learning dataset, aimed at providing more robust scoring of wall motion abnormalities.

3. Workflow Enhancement in SHD Domain with 3D Marker

As the role of echocardiography in structural heart disease (SHD) continues to evolve with medical advancements, the Transcend Plus series introduces the innovative 3D Marker function. This feature allows clinicians to place markers on 3D images or MPR sections, facilitating markedly quicker assessments and aiding in the comprehension of complex anatomical structures in time-critical scenarios.

Conclusion

The Transcend Plus series represents a significant step forward in the field of ultrasound diagnostics, combining high-quality imaging with advanced AI capabilities to tackle the increasing demands of modern healthcare. As Philips continues to innovate, the company aims to alleviate the burden on healthcare professionals while enhancing patient care in the fight against CVD.

Philips Japan, a subsidiary of Royal Philips founded in 1953, strives to improve people's health and well-being through its leadership in healthcare technology. Operating in various domains, including diagnostic imaging, ultrasound, and personal health, Philips works to address Japan's aging population and healthcare challenges. With around 2,000 employees across approximately 70 locations, Philips Japan is dedicated to advancing health technology for a better, healthier future.

For more information, please visit Philips Japan.